-
Koziarski Lab - The Hospital for Sick Children | Central Toronto Roselawn, Ontario | Canada | 10 days ago
machine learning-related discipline. Strong publication track record in top ML, computational chemistry, or computational biology conferences and journals. Proficiency in Python, demonstrated through
-
in the laboratory QUALIFICATIONS Successful applicants will have: PhD with expertise in cancer biology, proteomics and/or computational biology / machine learning A proven track record with first
-
applications. Mentor junior researchers and contribute to a collegial lab environment. Qualifications and Requirements PhD in Molecular Biology, Genomics, Cancer Biology, or a related field. Strong background in
-
Fellow appointment with benefits. Term: Two years Qualifications: The ideal candidate would have the following skills and attributes: PhD in Statistics, Quantitative Ecology, Mathematical Biology
-
background, as demonstrated by past publications, accomplishments, and references. Candidates with strong background in either computational or experimental biology (or both) will be considered. The successful
-
Postdoctoral Fellow in Islet Biology University of Alberta Competition 2564 Department Faculty of Medicine & Dentistry - Pharmacology Dept Non-Budgeted Salary range Hours per week - Grade Closing
-
, offering training and experience in genomics, computational biology, early drug discovery and clinical studies. RESPONSIBILITIES Reporting to Dr. Sam Aparicio, the incumbent will be responsible for: Design
-
to collaborative efforts aligned with translational and commercial development goals, including work supported by the CIFAR Multiscale Human Program and UBC’s Biodevice Foundry. Qualifications PhD in immunology
-
Human Program and UBC’s Biodevice Foundry. Qualifications PhD in immunology, developmental biology (focused on the immune system), immune-engineering, or a related field (obtained within the last 5 years
-
healing. The Granville research program spans basic molecular biology and biochemistry through to target validation, proof-of-concept in animal and human models, and collaborations with clinicians and